Month: January 2018

Flu vaccine Study Recruits First Participants

The world’s first NHS trial for a universal flu vaccine has recruited its first round of participants, with over 862 people signing up to take part since the trial launched in October 2017. This marks the end of the first phase of the trial, which will open again for...

Vaccitech secures £20m Series A with GV, OSI and Sequoia China

Vaccitech, an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products, has secured £20m ($27.1m) in Series A financing. The round was co-led by new investors GV, Sequoia China, and existing backer Oxford Sciences...